Jagasia, M; Beohou, E; van der Werf, S; Niederwieser, D; Dreger, P; Meijer, E; Chevallier, P; Sengeloev, H; Blaise, D; Petersen, E; Cornelissen, JJ; Ehninger, G; Gribben, J; Caballero, D; Beguin, Y; Hallek, M; Jindra, P; Fanin, R; Delage, J; Maertens, J; Gedde-Dahl, T; Montoto, S; Kroger, N; Greinix, H; Duarte, R.
Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses
BONE MARROW TRANSPL. 2017; 52: S83-S83.
Web of Science